Mustang Bio, Inc.

NASDAQ:MBIO

0.2224 (USD) • At close January 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Revenue 0002.8820000000000000000000-0.05000.050000000000
Cost of Revenue 00.30.6960.3631.3510.6980.8580.83400.6990.6790.6920.6340.540.490000000000000000000000
Gross Profit 0-0.3-0.6962.519-1.351-0.698-0.858-0.8340-0.699-0.679-0.692-0.634-0.54-0.4900000000-0.05000.050000000000
Gross Profit Ratio 0000.874000000000000000000010010000000000
Reseach & Development Expenses 0.0574.363.8046.3939.47710.8361417.03715.45915.16416.28917.47314.71311.90211.61818.3338.27411.139.56413.8738.0097.0237.4110.2246.3163.5574.36712.6132.4883.9941.2816.8290.5690.5820.5670.7630.57
General & Administrative Expenses 1.41.5311.4272.1792.1313.0552.3212.3953.3893.0773.3492.6462.3642.5383.4692.4052.1532.9911.9562.051.9873.1892.3441.6261.341.6832.113.1164.5961.6712.0251.0021.1010.4580.2550.080.088
Selling & Marketing Expenses 000-0.079000000000000000000000000000000000
SG&A 1.41.5311.4272.12.1313.0552.3212.3953.3893.0773.3492.6462.3642.5383.4692.4052.1532.9911.9562.051.9873.1892.3441.6261.341.6832.113.1164.5961.6712.0251.0021.1010.4580.2550.080.088
Other Expenses 02.649-1.016-0.0010.1380.429-0.351-0.6350.669005.8420.631010.0640.2871.30.256.2730.70.20.453.36100.07512.4330.31.506.07900000
Operating Expenses 1.4578.545.2318.49311.60813.89115.9718.79718.17918.24119.63820.11917.07714.4415.08720.73810.42714.12111.5215.9239.99610.2129.75411.857.6565.246.47715.7297.0845.6653.3067.8311.671.040.8220.8430.658
Operating Income -1.457-8.54-5.231-8.856-10.307-13.891-16.321-19.432-18.848-18.241-19.638-20.119-17.077-14.44-15.087-20.738-10.427-14.121-11.52-15.923-9.996-10.212-9.754-11.9-7.656-5.24-6.427-15.729-7.0845.665-3.30614.895-1.671.04-0.822-0.843-0.658
Operating Income Ratio 000-3.073000000000000000000023800-128.540000000000
Total Other Income Expenses Net 0.0470.3410.040.1250.249-2.344-0.372-0.202-0.149-0.858-0.1570.070.0720.0810.130.13-2.525-0.477-0.337-0.286-0.172-0.1870.1410.130.1380.1470.1460.1280.1440.1360.088-21.563-0.2-2.173-0.081-0.068-0.058
Income Before Tax -1.41-8.199-5.191-8.616-10.058-16.235-16.693-19.634-18.997-19.099-19.795-20.049-17.005-14.359-14.957-20.608-12.952-14.598-11.857-16.209-10.168-10.399-9.613-11.77-7.518-5.093-6.281-15.601-6.94-5.529-3.218-8.748-1.87-1.133-0.903-0.911-0.716
Income Before Tax Ratio 000-2.990000000000000000000235.400-125.620000000000
Income Tax Expense 0-0.3-0.696-4.542-0.3673.3611.5481.2171.7030.0770.1570.0040.0750.085-0.3560.1410.1620.1420.2630.3180.4060.3870.1520.569000.146000023.48200000
Net Income -1.41-8.199-5.191-8.616-10.058-16.235-18.241-20.851-18.997-19.099-19.952-20.049-17.005-14.359-14.957-20.608-12.952-14.598-11.857-16.209-10.168-10.399-9.613-11.77-7.518-5.093-6.281-15.601-6.94-5.529-3.218-8.748-1.87-1.133-0.903-0.911-0.716
Net Income Ratio 000-2.990000000000000000000235.400-125.620000000000
EPS -0.038-1.1-0.46-0.93-1.23-2-2.25-2.91-2.42-2.5-3.06-3.42-2.8-2.46-2.79-5.88-3.39-4.86-4.24-6.74-3.82-4.3-5.16-6.53-4.15-2.82-3.57-9.1-3.98-3.16-1.84-5-1.07-0.65-0.52-0.75-1.07
EPS Diluted -0.038-1.1-0.46-0.93-1.23-2-2.25-2.91-2.42-2.5-3.06-3.42-2.8-2.46-2.79-5.88-3.39-4.86-4.24-6.74-3.82-4.3-5.16-6.53-4.15-2.82-3.57-9.1-3.98-3.16-1.84-5-1.07-0.65-0.52-0.75-1.07
EBITDA -1.358-7.897-4.494-8.253-9.672-15.4-14.659-17.64-17.144-17.465-18.886-19.353-16.368-13.819-14.463-20.116-9.84-13.554-10.853-15.224-9.275-9.49-9.284-11.452-7.318-4.978-6.274-15.591-7.084-5.665-3.216-7.815-1.668-1.04-0.822-0.843-0.658
EBITDA Ratio 000-2.9470000000000000000000220.4200-125.480000000000